Silent Ischaemia: To treat or not to treat?

Indian Heart Journal

Volumn 48, Issue 4, 1996, Pages 415-419

  Deedwania, Prakash C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; NITRATE;

HUMAN; ISCHEMIA; PREVALENCE; PROGNOSIS; SHORT SURVEY;

CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; DECISION MAKING; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PREVALENCE; PROGNOSIS;

EID: 0029795284     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Deedwania PC, Carbajal EV. Silent myocardial ischaemia - a clinical perspective. Arch Intern Med 1991; 151: 2373-2382
2. Gottlieb SO, Weisfeldt ML, Ouyant P, Mellits ED, Gerstenblith G. Silent ischaemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986; 314: 1214-1219
3. Gottlieb SO, Gottlieb SH, Achuff SC, Baumgardner R, Mellits ED, Weisfeldt ML, et al. Silent ischaemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA 1988; 259: 1030-1035
4. Tzivoni D, Gavish A, Zin D, Gottlieb S, Moriel M, Keren A, et al. Prognostic significance of ischaemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988; 62: 661-664
5. Deedwania P, Carbajal E. Prevalence and patterns of silent myocardial ischaemia during daily life instable angina patients receiving conventional antianginal drug therapy. Am J Cardiol 1990; 65: 1090-1096
6. Deedwania P, Carbajal EV. Silent ischaemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990; 81: 748-756
7. Deedwania PC. Asymptomatic ischaemia during pre-discharge Holter monitoring predicts poor prognosis in the postinfarction period. Am J Cardiol 1993; 71: 859
8. Deedwania PC. Does myocardial ischaemia portend poor prognosis? (editorial) J Am Coll Cardiol 1994; 23(1): 229-232
9. Yeung A, Barry J, Orav J, Bonassin E, Raby K, Selwyn A. Effect of asymptomatic ischaemia on long-term prognosis in chronic stable coronary disease. Circulation 1991; 83: 1598-1604
10. Stone P, Gibson R, Glasser S, DeWood M, Parker J, Kawanishi D, et al. Comparison of propranolol, diltiazem and nifedipine in the treatment of ambulatory ischaemia in patients with stable angina. Circulation 1990; 82: 1962-1972
11. Deedwania PC, Carbajal EV, Nelson JR, Hait H. Anti-ischaemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischaemia. J Am Coll Cardiol 1991; 17: 963-969
12. Knatterud G, Bourassa M, Pepine C, Geller N, Sopki G, Chairman B, et al. Effects of treatment strategies to suppress ischaemia in patients with coronary artery disease: 12-week results of the asymptomatic cardiac ischaemia (ACIP) study. J Am Coll Cardiol 1994; 24: 11-20
13. Pepine C, Cohn P, Deedwania P, Gibson R, Handberg E, Hill J et al. Effects of treatment on outcome in mildly symptomatic patients with ischaemia during daily life. The atenolol silent ischaemia study. Circulation 1994; 90: 762-768
14. Rogers W, Bourassa M, Andrews T, Bertolet B, Blumenthal R, Chaitman B, et al. Asymptomatic cardiac ischaemia pilot study: outcome at 1 year for patients with ischaemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1995; 26: 594-605
15. Deedwania P. Is there evidence in support of the ischaemia suppression hypothesis? J Am Coll Cardiol 1994; 24: 21-24
16. Deedwania P. Should asymptomatic subjects with silent ischaemia undergo further evaluation and follow-up? Int J Cardiol 44: 1994: 101-103
17. Deedwania P. The need for a cost-effective strategy to detect ambulatory silent ischaemia. Am J Cardiol 74; 1994: 1061-1062
18. Multiple Risk Factor Intervention Trial Research Group. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1985; 55: 16-24
19. Gordon D, Ekelund L, Karon J, et al. Predictive value of the exercise tolerance test for mortality in North American men: the lipid research clinics mortality follow-up study. Circulation 1986; 74: 252-261
20. Weiner D, Ryan T, McCabe C, Ng G, et al. Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischaemia: a report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 1988; 62: 1155-1161
21. Geft I, Fischbein M, Ninomiya K. Intermittent brief periods of ischaemia have a cumulative effect and may cause myocardial necrosis. Circulation 1982; 66: 1150-1153
22. Schaper J. Effects of multiple ischaemic events on human myocardium: an ultrastructural study. Eur Heart J 1988; 9 (suppl A): 141-149
23. Hess O, Schneider J, Nonogi H, et al. Myocardial structure in patients with exercise induced ischaemia. Circulation 1977; 5: 967-977
24. Deedwania P, Nelson J. Pathophysiology of silent myocardial ischaemia during daily life: Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990; 82: 1296-1304
25. Deedwania P. Mental stress, pain perception and risk of silent ischaemia. J Am Coll Cardiol 1995; 25: 1504-1506
26. Bourassa M, Pepine C, Forman S, Rogers W, Dyrda I, Stone P, et al. Asymptomatic cardiac ischaemia pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass surgery on recurrent angina and ischaemia. J Am Coll Cardiol 1995; 26: 606-614
27. Von Arnim T, for the TIBBS Investigators. Prognostic significance of transient ischaemic episodes: response to treatment shows improved prognosis. Results of the Total Ischaemic Burden Bisoprolol Study (TIBBS) Follow-Up. J Am Coll Cardiol 1996; 28: 20-24